MSB 3.21% $1.13 mesoblast limited

Will the FDA refuse approval in the face of the favourable ODAC 9 versus 1 vote?, page-52

  1. 3,132 Posts.
    lightbulb Created with Sketch. 1620
    I guess I missed the bit in the advisory hearing where they said they didn’t believe it had efficacy and required further testing. Can you please quote for me where that bit appeared?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.